MARKET INTRODUCTION
Prophylactic Human Vaccines gives protection against human papillomavirus (HPV) infection. There are nearly 200 types of HPV among which 40 transmitted by sexual contact and some of them also known to produce malignancies such as, cervical, penile, vulvar, vaginal etc. The prophylactic human vaccines have weakened microbes which are further stimulated by body to produce antibodies for encountering HPV.
MARKET DYNAMICS
The key market drivers for Prophylactic Human Vaccines Market Includes, rising prevalence of cervical cancers as well as increased in HPV infection. Moreover, government initiatives for boosting R&D activities for vaccine production is also expected to fuel market growth during forecast period. Whereas, high cost of overall research and high cost of vaccine is expected to restrain market growth during the forecast period.
MARKET SCOPE
The "Prophylactic Human Vaccines Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Prophylactic Human Vaccines market with detailed market segmentation by vaccine technology. The Prophylactic Human Vaccines Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Prophylactic Human Vaccines Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Prophylactic Human Vaccines Market is segmented on the basis of vaccine technology. SO on the basis of vaccine technology the market is segmented as, live attenuated vaccines, inactive vaccines, toxoid vaccine, polysaccharide vaccines, conjugate vaccines, recombinant vaccines.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Prophylactic Human Vaccines Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Prophylactic Human Vaccines Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Prophylactic Human Vaccines Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Prophylactic Human Vaccines Market in these regions.
MARKET PLAYERS
The report covers key developments in the Prophylactic Human Vaccines Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Prophylactic Human Vaccines Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Prophylactic Human Vaccines market in the global market. Below mentioned is the list of few companies engaged in the Prophylactic Human Vaccines Market.
The report also includes the profiles of key players in Prophylactic Human Vaccines Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- GlaxoSmithKline Plc.
- Merck and Co., Inc.
- Pfizer, Inc.
- Janssen Pharmaceuticals, Inc.
- Altimmune, Inc.
- Bharat Biotech Limited
- Serum Institute of India, Pvt. Ltd
- Sanofi Pasteur SA
- Shanghai BravoBio Co., Ltd.
- SK Chemicals Co., Ltd.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prophylactic Human Vaccines Market - By Vaccine Technology
1.3.2 Prophylactic Human Vaccines Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROPHYLACTIC HUMAN VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. PROPHYLACTIC HUMAN VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PROPHYLACTIC HUMAN VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. PROPHYLACTIC HUMAN VACCINES - GLOBAL MARKET OVERVIEW
6.2. PROPHYLACTIC HUMAN VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PROPHYLACTIC HUMAN VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TECHNOLOGY
7.1. OVERVIEW
7.2. VACCINE TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. LIVE ATTENUATED VACCINES
7.3.1. Overview
7.3.2. Live Attenuated Vaccines Market Forecast and Analysis
7.4. INACTIVATED VACCINES
7.4.1. Overview
7.4.2. Inactivated Vaccines Market Forecast and Analysis
7.5. TOXOID VACCINES
7.5.1. Overview
7.5.2. Toxoid Vaccines Market Forecast and Analysis
7.6. POLYSACCHARIDE VACCINES
7.6.1. Overview
7.6.2. Polysaccharide Vaccines Market Forecast and Analysis
7.7. CONJUGATE VACCINES
7.7.1. Overview
7.7.2. Conjugate Vaccines Market Forecast and Analysis
7.8. RECOMBINANT VACCINES
7.8.1. Overview
7.8.2. Recombinant Vaccines Market Forecast and Analysis
8. PROPHYLACTIC HUMAN VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Prophylactic Human Vaccines Market Overview
8.1.2 North America Prophylactic Human Vaccines Market Forecasts and Analysis
8.1.3 North America Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.1.4 North America Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.1.4.1 United States Prophylactic Human Vaccines Market
8.1.4.1.1 United States Prophylactic Human Vaccines Market by Vaccine Technology
8.1.4.2 Canada Prophylactic Human Vaccines Market
8.1.4.2.1 Canada Prophylactic Human Vaccines Market by Vaccine Technology
8.1.4.3 Mexico Prophylactic Human Vaccines Market
8.1.4.3.1 Mexico Prophylactic Human Vaccines Market by Vaccine Technology
8.2. EUROPE
8.2.1 Europe Prophylactic Human Vaccines Market Overview
8.2.2 Europe Prophylactic Human Vaccines Market Forecasts and Analysis
8.2.3 Europe Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.2.4 Europe Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Prophylactic Human Vaccines Market
8.2.4.1.1 Germany Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.2 France Prophylactic Human Vaccines Market
8.2.4.2.1 France Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.3 Italy Prophylactic Human Vaccines Market
8.2.4.3.1 Italy Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.4 Spain Prophylactic Human Vaccines Market
8.2.4.4.1 Spain Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.5 United Kingdom Prophylactic Human Vaccines Market
8.2.4.5.1 United Kingdom Prophylactic Human Vaccines Market by Vaccine Technology
8.2.4.6 Rest of Europe Prophylactic Human Vaccines Market
8.2.4.6.1 Rest of Europe Prophylactic Human Vaccines Market by Vaccine Technology
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Prophylactic Human Vaccines Market Overview
8.3.2 Asia-Pacific Prophylactic Human Vaccines Market Forecasts and Analysis
8.3.3 Asia-Pacific Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.3.4 Asia-Pacific Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Prophylactic Human Vaccines Market
8.3.4.1.1 Australia Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.2 China Prophylactic Human Vaccines Market
8.3.4.2.1 China Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.3 India Prophylactic Human Vaccines Market
8.3.4.3.1 India Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.4 Japan Prophylactic Human Vaccines Market
8.3.4.4.1 Japan Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.5 South Korea Prophylactic Human Vaccines Market
8.3.4.5.1 South Korea Prophylactic Human Vaccines Market by Vaccine Technology
8.3.4.6 Rest of Asia-Pacific Prophylactic Human Vaccines Market
8.3.4.6.1 Rest of Asia-Pacific Prophylactic Human Vaccines Market by Vaccine Technology
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Prophylactic Human Vaccines Market Overview
8.4.2 Middle East and Africa Prophylactic Human Vaccines Market Forecasts and Analysis
8.4.3 Middle East and Africa Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.4.4 Middle East and Africa Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Prophylactic Human Vaccines Market
8.4.4.1.1 South Africa Prophylactic Human Vaccines Market by Vaccine Technology
8.4.4.2 Saudi Arabia Prophylactic Human Vaccines Market
8.4.4.2.1 Saudi Arabia Prophylactic Human Vaccines Market by Vaccine Technology
8.4.4.3 U.A.E Prophylactic Human Vaccines Market
8.4.4.3.1 U.A.E Prophylactic Human Vaccines Market by Vaccine Technology
8.4.4.4 Rest of Middle East and Africa Prophylactic Human Vaccines Market
8.4.4.4.1 Rest of Middle East and Africa Prophylactic Human Vaccines Market by Vaccine Technology
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Prophylactic Human Vaccines Market Overview
8.5.2 South and Central America Prophylactic Human Vaccines Market Forecasts and Analysis
8.5.3 South and Central America Prophylactic Human Vaccines Market Forecasts and Analysis - By Vaccine Technology
8.5.4 South and Central America Prophylactic Human Vaccines Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Prophylactic Human Vaccines Market
8.5.4.1.1 Brazil Prophylactic Human Vaccines Market by Vaccine Technology
8.5.4.2 Argentina Prophylactic Human Vaccines Market
8.5.4.2.1 Argentina Prophylactic Human Vaccines Market by Vaccine Technology
8.5.4.3 Rest of South and Central America Prophylactic Human Vaccines Market
8.5.4.3.1 Rest of South and Central America Prophylactic Human Vaccines Market by Vaccine Technology
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. PROPHYLACTIC HUMAN VACCINES MARKET, KEY COMPANY PROFILES
10.1. GLAXOSMITHKLINE PLC
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. MERCK AND CO., INC
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. PFIZER, INC
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. JANSSEN PHARMACEUTICALS, INC
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. ALTIMMUNE, INC
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. BHARAT BIOTECH INTERNATIONAL LIMITED
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. SERUM INSTITUTE OF INDIA PVT LTD
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. SANOFI PASTEUR SA
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. SHANGHAI BRAVOBIO CO., LTD
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. SK CHEMICALS CO., LTD
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies
1. GlaxoSmithKline Plc
2. Merck and Co., Inc
3. Pfizer, Inc
4. Janssen Pharmaceuticals, Inc
5. Altimmune, Inc
6. Bharat Biotech International Limited
7. Serum Institute of India Pvt Ltd
8. Sanofi Pasteur SA
9. Shanghai BravoBio Co., Ltd
10. SK Chemicals Co., Ltd
Global Loop-mediated Isothermal Amplific..
According to this latest study, the 2020 growth of Loop-medi..
+1-646-791 7070US (Toll Free)